June 30, 2025
Drug Pricing Policy: A Global Perspective
The recent executive order on "Most-Favored-Nation" (MFN) drug pricing, signed by President Trump…
June 23, 2025
Navigating PARP Inhibitor Reimbursement Policies
The recent reassessment of PARP inhibitor reimbursement by Zorginstituut Nederland marks a significant…
June 16, 2025
NICE Approves Belantamab Mafodotin for Multiple Myeloma
The National Institute for Health and Care Excellence (NICE) has approved Belantamab Mafodotin,…
June 9, 2025
Maximising Efficiency with AI in Clinical Trials
The integration of AI in clinical trials offers significant potential to enhance efficiency,…
June 2, 2025
NCD Priorities: Pharmaceutical Industry’s Role Ahead of UN Meeting
Non-communicable diseases (NCDs) pose a significant global health and economic challenge. As we…
May 26, 2025
Enhancing Clinical Trials with Public-Private Partnerships
Public-private partnerships are transforming the clinical trials landscape, particularly in Europe. These collaborations…
